An EU Logo for Safer Online Shopping for Medicines
Client Alert | 3 min read | 08.27.15
As of July 1, 2015, all internet sites that sell medicines to the public in the EU Member States (plus Norway, Iceland, and Lichtenstein) have to display a common logo established by the EU Commission.
The common logo allows the general public to easily and quickly verify that an online seller is a legal registered pharmacy or retailer by clicking on the logo, which redirects the shopper to the registration listings on the official website of the governing authorities of the EU Member States. This registration and verification process is intended to diminish the risk that consumers will purchase fraudulent or fake medicines online.
Origin of the common logo
To reduce the threat to public health and safety associated with the online sale of fraudulent and fake medicines, the EU Commission introduced the concept of a common logo that would be recognizable throughout the EU and would identify legal, registered online pharmacies and retailers in Directive 2011/62/EU of June 8, 2011. That Directive amended Directive 2001/83/EC, which addresses medicinal products for human use and prevents the entry into commerce of falsified medicinal products (the "Falsified Medicines Directive").
In Implementing Regulation 699/2014 of June 24, 2014 (Implementing Regulation), the EU Commission used the power granted by the Falsified Medicines Directive to i) develop and adopt a new common logo for identifying persons authorized to sell medicines online, and ii) to specify the technical, electronic, and cryptographic requirements to verify the authenticity of that common logo.
The Implementing Regulation granted Member States approximately one year to introduce the common logo into their national legislation.
This transition period ended on June 30, 2015. As of July 1, 2015, the EU common logo must appear on every website page that offers medicines for sale to the public in the EU, including every page of third-party websites that offer a marketplace for online sales of medicines.
Look and feel of the common logo
As shown in the example for Belgium, below, the left-hand side of the EU common logo is the national flag of the EU Member State where the online supplier is established. Next to the flag, the phrase "Click to verify if the website is operating legally" appears in the language of the EU Member State where the online supplier is established and links to the official registration page for online pharmacies and retailers who have been authorized to sell medicines by the national governing authority. In addition, the Implementing Regulation requires the EU common logo to be static, to have a minimum width of 90 pixels, and to use specific reference colors.
For Belgium the common logo will look as follows:
Other Articles in This Month's Edition:
- Third Circuit Upholds the FTC’s Authority to Regulate 'Unfair' Data Security Practices
- Senator Markey Introduces the SPY Car Act to Regulate Automotive Cybersecurity
- FDA Loses Battle to Limit Truthful, Non-Misleading Off-Label Promotion of Approved Drugs
- A Hashtag Away from a Warning Letter? Kim Kardashian's Instagram Post Triggers FDA Warning Letter that Sends a Strong Message to Drug Makers
- Got Lead? Significant Changes to Proposition 65's Lead MADL May Be on the Horizon
- Advertisers in the Ring – A Roundup of This Month's Competitor Advertising Challenges: Unique Features and Outstanding Reviews – What Counts?
Contacts
Insights
Client Alert | 3 min read | 11.21.25
On November 7, 2025, in Thornton v. National Academy of Sciences, No. 25-cv-2155, 2025 WL 3123732 (D.D.C. Nov. 7, 2025), the District Court for the District of Columbia dismissed a False Claims Act (FCA) retaliation complaint on the basis that the plaintiff’s allegations that he was fired after blowing the whistle on purported illegally discriminatory use of federal funding was not sufficient to support his FCA claim. This case appears to be one of the first filed, and subsequently dismissed, following Deputy Attorney General Todd Blanche’s announcement of the creation of the Civil Rights Fraud Initiative on May 19, 2025, which “strongly encourages” private individuals to file lawsuits under the FCA relating to purportedly discriminatory and illegal use of federal funding for diversity, equity, and inclusion (DEI) initiatives in violation of Executive Order 14173, Ending Illegal Discrimination and Restoring Merit-Based Opportunity (Jan. 21, 2025). In this case, the court dismissed the FCA retaliation claim and rejected the argument that an organization could violate the FCA merely by “engaging in discriminatory conduct while conducting a federally funded study.” The analysis in Thornton could be a sign of how forthcoming arguments of retaliation based on reporting allegedly fraudulent DEI activity will be analyzed in the future.
Client Alert | 3 min read | 11.20.25
Client Alert | 3 min read | 11.20.25
Client Alert | 6 min read | 11.19.25
